Table 1A.
Characteristics | Decitabine (n=20) | Conventional Care (n=25) | p-value |
---|---|---|---|
Age, median [range], years | 62, [24–79] | 53 [31–72] | 0.10 |
≤ 60 | 9 (45) | 18 (72) | 0.12 |
> 60 | 11 (55) | 7 (28) | |
| |||
CR1 | 14 (70) [1CRp] | 21 (83) [1CRp] | 0.26 |
CR2 | 6 (30) [1CRp] | 3 (12) | |
CR3 | 0 | 1 (4) | |
| |||
Induction regimen | 0.20 | ||
SDAC + Anthracycline (3+7) | 7 (35) | 3 (12) | |
HiDAC + Anthracycline | 11 (55) | 18 (72) | |
Single agent (e.g. Clofarabine) | 2 (10) | 4 (16) | |
| |||
No. of consolidation cycles | 0.19 | ||
≤ 1 | 8 (40) | 5 (20) | |
> 1 | 12 (60) | 20 (80) | |
| |||
Cytogenetics | 0.99 | ||
Intermediate | 15 (75) | 19 (76) | |
Unfavorable | 5 (25) | 5 (20) | |
Favorable (relapsed) | 0 | 1 (4) |